Francesca Passarelli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Case Report: Erythema gyratum repens associated with adenomyosis and endometriosis: an immunological twist?
Journal: Frontiers in immunology
Published: March 20, 2026
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases.
Journal: Frontiers in immunology
Published: February 04, 2026
Neoplastic Foot Ulcers: A Multicentre Retrospective Study.
Journal: International wound journal
Published: November 26, 2025
Syphilis, the great mimicker: an inverted diagnostic pathway that still hits the mark.
Journal: Dermatology reports
Published: August 21, 2025
Early inflammatory biomarkers and melanoma survival.
Journal: International journal of dermatology
Published: July 18, 2022
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma.
Journal: Biomedicines
Published: November 16, 2021
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study.
Journal: Journal of the American Academy of Dermatology
Published: October 15, 2021
Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI).
Journal: Dermatology reports
Published: May 31, 2021
The integrated care pathway for non melanoma skin cancer: the Istituto Dermopatico dell'Immacolata - IRCCS experience in Rome.
Journal: Recenti progressi in medicina
Published: December 28, 2020
Pseudoangiomatous stromal hyperplasia: an unsuspected cause of anisomasty.
Journal: Case reports in plastic surgery & hand surgery
Published: November 02, 2020
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.
Journal: Immunity, inflammation and disease
Published: October 20, 2020
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab.
Journal: Frontiers in immunology
Published: July 03, 2020
Last Updated: 09/26/2026